NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$3.27
+4.47%Margins
Gross margin
87.2%
EBITDA margin
74.9%
EBIT margin
66.7%
Net margin
74.1%
FCF margin
0.0%
21.2%
Return on equity
21.2%
Return on assets
19.1%
Return on invested capital
0.29x
Asset turnover
$0.00
Cash from operations
$0.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025